About InfuSystem (NYSEAMERICAN:INFU)
InfuSystem Holdings, Inc. is a provider of infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers and other sites of care. The Company delivers local, field-based customer support and also operates pump service and repair Centers of Excellence in Michigan, Kansas, California, Texas and Ontario, Canada. Its service is to supply electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics and hospital outpatient chemotherapy clinics for the treatment of a range of cancers, including colorectal cancer, pain management and other disease states. It sells or rents new and pre-owned pole mounted and ambulatory infusion pumps to, and provides biomedical recertification, maintenance and repair services for oncology practices, as well as other alternate site settings, including home care and home infusion providers, skilled nursing facilities, pain centers and others.
Industry, Sector and Symbol
Industry Medical Equipment, Supplies & Distribution
Trailing P/E Ratio-17.1428571428571
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on Equity-1.06%
Return on Assets-0.59%
InfuSystem (NYSEAMERICAN:INFU) Frequently Asked Questions
What is InfuSystem's stock symbol?
InfuSystem trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "INFU."
How will InfuSystem's stock buyback program work?
InfuSystem announced that its board has authorized a share buyback program on Tuesday, March 13th 2018, which allows the company to buyback 1,000,000 outstanding shares, according to EventVestor. This buyback authorization allows the company to reacquire shares of its stock through open market purchases. Stock buyback programs are usually a sign that the company's board of directors believes its shares are undervalued.
How were InfuSystem's earnings last quarter?
InfuSystem Holdings Inc (NYSEAMERICAN:INFU) announced its earnings results on Tuesday, March, 13th. The medical instruments supplier reported ($0.03) EPS for the quarter. The medical instruments supplier had revenue of $18.89 million for the quarter. InfuSystem had a negative net margin of 0.73% and a negative return on equity of 1.06%. View InfuSystem's Earnings History.
Who are some of InfuSystem's key competitors?
Some companies that are related to InfuSystem include Pfenex (PFNX), TSO3 (TOS), Asterias Biotherapeutics (AST), Tissue Regenix Group (TRX), Matinas BioPharma (MTNB), Motif Bio (MTFB), Ergomed (ERGO), Bioquell (BQE), Nexvet Biopharma (NVET), Bovie Medical (BVX), OncoCyte (OCX), Navidea Biopharmaceuticals (NAVB), Aegerion Pharmaceuticals (AEGR), Amryt Pharma (AMYT), NovaBay Pharmaceuticals (NBY), Rexahn Pharmaceuticals (RNN), Abzena (ABZA) and Scancell (SCLP).
Who are InfuSystem's key executives?
InfuSystem's management team includes the folowing people:
- Gregg O. Lehman Ph.D., Executive Chairman of the Board (Age 67)
- Richard A. Diiorio, President, Chief Executive Officer, Director (Age 43)
- Christopher Downs, Interim Chief Financial Officer, Executive Vice President (Age 59)
- Janet Skonieczny, Chief Operating Officer, Executive Vice President, Compliance Officer and Privacy Officer (Age 56)
- Trent N Smith, Executive Vice President, Chief Accounting Officer, Corporate Controller (Age 48)
- Michael Milton McReynolds, Executive Vice President, Chief Information Officer (Age 46)
- Darrell B. Montgomery, Director (Age 55)
- Ryan J. Morris, Director (Age 32)
- Christopher R. Sansone, Director
- Scott A. Shuda, Director (Age 50)
Has InfuSystem been receiving favorable news coverage?
Media coverage about INFU stock has been trending somewhat positive recently, according to Accern Sentiment. The research group identifies positive and negative press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. InfuSystem earned a media sentiment score of 0.06 on Accern's scale. They also gave media headlines about the medical instruments supplier an impact score of 46.66 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next several days.
Who are InfuSystem's major shareholders?
InfuSystem's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include AWM Investment Company Inc. (6.65%), LSV Asset Management (0.77%) and Renaissance Technologies LLC (0.52%). Company insiders that own InfuSystem stock include Christopher Downs, Christopher R Sansone, Darrell B Montgomery, Eric K Steen, Meridian Ohc Partners, Lp, Richard Dilorio and Ryan J Morris. View Institutional Ownership Trends for InfuSystem.
Which major investors are selling InfuSystem stock?
Which major investors are buying InfuSystem stock?
INFU stock was bought by a variety of institutional investors in the last quarter, including AWM Investment Company Inc. and Renaissance Technologies LLC. Company insiders that have bought InfuSystem stock in the last two years include Christopher Downs, Christopher R Sansone, Darrell B Montgomery, Eric K Steen, Meridian Ohc Partners, Lp, Richard Dilorio and Ryan J Morris. View Insider Buying and Selling for InfuSystem.
How do I buy shares of InfuSystem?
Shares of INFU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is InfuSystem's stock price today?
One share of INFU stock can currently be purchased for approximately $2.40.
How big of a company is InfuSystem?
InfuSystem has a market capitalization of $53.53 million.
How can I contact InfuSystem?
InfuSystem's mailing address is 31700 Research Park Dr, MADISON HEIGHTS, MI 48071-4627, United States. The medical instruments supplier can be reached via phone at +1-248-2911210.
MarketBeat Community Rating for InfuSystem (INFU)MarketBeat's community ratings are surveys of what our community members think about InfuSystem and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
InfuSystem (NYSEAMERICAN:INFU) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
InfuSystem (NYSEAMERICAN:INFU) Earnings History and Estimates Chart
InfuSystem (NYSEAMERICAN INFU) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|3/13/2018||Q4 2017||($0.03)||$18.89 million||View||Listen|
|11/10/2017||Q3 2017||($0.01)||$17.59 million||View||N/A|
|8/9/2017||Q2 2017||($0.02)||$16.94 million||View||Listen|
|5/11/2017||Q1 2017||($0.06)||$17.65 million||View||N/A|
|3/22/2017||Q4 2016||$0.07||($0.01)||$16.85 million||View||N/A|
|12/12/2016||Q3 2016||$0.00||$17.23 million||View||N/A|
|8/10/2016||Q216||$0.04||$17.20 million||$19.10 million||View||Listen|
|5/10/2016||Q116||$0.02||$16.70 million||$19.00 million||View||N/A|
|3/9/2016||Q4 2015||$0.09||$19.54 million||View||N/A|
|8/13/2015||Q2 2015||$0.05||$17.17 million||View||N/A|
|5/12/2015||Q115||$0.06||$0.03||$17.20 million||$16.70 million||View||Listen|
|3/9/2015||Q414||$0.05||$0.05||$17.20 million||$16.20 million||View||N/A|
|11/10/2014||Q3 2014||$0.05||$0.04||$16.61 million||View||N/A|
|8/1/2014||Q2 2014||$0.04||$16.37 million||View||N/A|
|5/5/2014||Q1 2014||$0.03||$0.03||$17.24 million||View||N/A|
InfuSystem (NYSEAMERICAN:INFU) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for InfuSystem (NYSEAMERICAN:INFU)
No dividend announcements for this company have been tracked by MarketBeat.com
InfuSystem (NYSEAMERICAN INFU) Insider Trading and Institutional Ownership History
InfuSystem (NYSEAMERICAN INFU) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|3/16/2018||Meridian Ohc Partners, Lp||Director||Buy||20,000||$2.40||$48,000.00|| |
|12/13/2017||Meridian Ohc Partners, Lp||Director||Buy||64,000||$2.32||$148,480.00|| |
|12/8/2017||Meridian Ohc Partners, Lp||Director||Buy||1,800||$2.30||$4,140.00|| |
|12/6/2017||Meridian Ohc Partners, Lp||Director||Buy||7,300||$2.30||$16,790.00|| |
|11/27/2017||Christopher R Sansone||Director||Buy||2,000||$2.20||$4,400.00|| |
|11/21/2017||Christopher R Sansone||Director||Buy||54,344||$2.09||$113,578.96|| |
|9/11/2017||Meridian Ohc Partners, Lp||Director||Buy||19,982||$2.00||$39,964.00|| |
|8/30/2017||Meridian Ohc Partners, Lp||Director||Buy||30,900||$1.90||$58,710.00|| |
|8/28/2017||Meridian Ohc Partners, Lp||Director||Buy||30,000||$1.90||$57,000.00|| |
|8/25/2017||Meridian Ohc Partners, Lp||Director||Buy||13,381||$1.84||$24,621.04|| |
|8/24/2017||Meridian Ohc Partners, Lp||Director||Buy||155||$1.80||$279.00|| |
|8/23/2017||Meridian Ohc Partners, Lp||Director||Buy||2,166||$1.80||$3,898.80|| |
|8/16/2017||Meridian Ohc Partners, Lp||Director||Buy||56,670||$1.84||$104,272.80|| |
|8/15/2017||Richard Dilorio||Director||Buy||4,875||$1.95||$9,506.25||59,659|| |
|8/14/2017||Christopher Downs||CFO||Buy||7,900||$1.90||$15,010.00||28,840|| |
|8/14/2017||Darrell B Montgomery||Director||Buy||25,000||$1.88||$47,000.00||12,000|| |
|6/7/2017||Meridian Ohc Partners, Lp||Director||Buy||10,109||$1.55||$15,668.95|| |
|6/2/2017||Meridian Ohc Partners, Lp||Director||Buy||10,100||$1.55||$15,655.00|| |
|5/25/2017||Meridian Ohc Partners, Lp||Director||Buy||6,105||$1.55||$9,462.75|| |
|5/19/2017||Ryan J Morris||Director||Buy||15,000||$1.28||$19,200.00|| |
|5/17/2017||Ryan J Morris||Director||Buy||29,614||$1.45||$42,940.30|| |
|3/27/2017||Ryan J Morris||Director||Buy||21,651||$2.20||$47,632.20|| |
|3/24/2017||Ryan J Morris||Director||Buy||94,200||$2.14||$201,588.00|| |
|12/19/2016||Eric K. Steen||Insider||Buy||12,000||$2.33||$27,960.00|| |
|12/16/2016||Meridian Ohc Partners, Lp||Director||Buy||200,000||$2.34||$468,000.00|| |
|9/14/2016||Ryan J Morris||Director||Buy||23,171||$2.85||$66,037.35|| |
|9/13/2016||Ryan J Morris||Director||Buy||16,829||$2.88||$48,467.52|| |
|9/8/2016||Ryan J Morris||Director||Buy||17,171||$2.84||$48,765.64|| |
|9/2/2016||Ryan J Morris||Director||Buy||4,600||$2.84||$13,064.00|| |
|11/19/2015||Eric K. Steen||CEO||Buy||2,461||$2.88||$7,087.68||157,217|| |
|11/12/2015||Meridian Ohc Partners, Lp||Major Shareholder||Buy||29,600||$2.82||$83,472.00|| |
|11/3/2015||Meridian Ohc Partners, Lp||Major Shareholder||Buy||7,689||$2.75||$21,144.75|| |
|10/28/2015||Meridian Ohc Partners, Lp||Major Shareholder||Buy||17,100||$2.71||$46,341.00|| |
|10/13/2015||Meridian Ohc Partners, Lp||Major Shareholder||Buy||14,290||$2.82||$40,297.80|| |
|10/12/2015||Meridian Ohc Partners, Lp||Major Shareholder||Buy||1,860||$2.83||$5,263.80|| |
|8/24/2015||Eric K. Steen||CEO||Buy||5,000||$2.83||$14,150.00||152,191|| |
|8/19/2015||Eric K. Steen||CEO||Buy||7,360||$2.92||$21,491.20||147,191|| |
|8/18/2015||Jonathan P Foster||CFO||Buy||1,000||$2.92||$2,920.00|| |
|6/23/2015||Meridian Ohc Partners, Lp||Major Shareholder||Buy||7,500||$3.19||$23,925.00|| |
|6/15/2015||Gregg Owen Lehman||Director||Buy||2,000||$3.23||$6,460.00|| |
|6/12/2015||Meridian Ohc Partners, Lp||Major Shareholder||Buy||12,786||$3.16||$40,403.76|| |
|6/8/2015||Gregg Owen Lehman||Director||Buy||18,000||$3.19||$57,420.00|| |
|6/4/2015||David C Dreyer||Director||Sell||10,000||$3.15||$31,500.00|| |
|6/4/2015||Meridian Ohc Partners, Lp||Major Shareholder||Buy||19,550||$3.15||$61,582.50|| |
|5/19/2015||Eric K Steen||CEO||Buy||5,682||$3.08||$17,500.56|| |
|5/15/2015||Jonathan P Foster||CFO||Buy||4,270||$3.07||$13,108.90|| |
|12/16/2014||Eric K Steen||CEO||Buy||15,100||$2.73||$41,223.00|| |
|12/4/2014||Eric K Steen||CEO||Buy||3,669||$2.65||$9,722.85|| |
|11/26/2014||Eric K Steen||CEO||Buy||10,000||$2.75||$27,500.00|| |
|11/17/2014||Eric K Steen||CEO||Buy||10,000||$2.69||$26,900.00|| |
|8/27/2014||Eric K Steen||CEO||Buy||15,000||$2.75||$41,250.00|| |
|8/18/2014||Eric K Steen||CEO||Buy||12,750||$2.79||$35,572.50|| |
|8/13/2014||Eric K Steen||CEO||Buy||7,262||$2.79||$20,260.98|| |
|8/11/2014||Eric K Steen||CEO||Buy||11,172||$2.71||$30,276.12|| |
|5/7/2014||Eric K Steen||CEO||Buy||10,000||$2.80||$28,000.00|| |
|3/17/2014||Ryan J Morris||Chairman||Sell||24,600||$2.90||$71,340.00|| |
|3/13/2014||Jonathan P Foster||CFO||Buy||5,000||$2.78||$13,900.00|| |
|8/14/2013||Eric K Steen||CEO||Buy||15,000||$1.42||$21,300.00|| |
InfuSystem (NYSEAMERICAN INFU) News Headlines
|Edited Transcript of INFU earnings conference call or presentation 13-Mar-18 2:00pm GMT|
finance.yahoo.com - March 18 at 9:32 AM
|Meridian Ohc Partners, Lp Buys 20,000 Shares of InfuSystem Holdings Inc (INFU) Stock|
www.americanbankingnews.com - March 16 at 8:52 PM
|InfuSystem (INFU) Releases Earnings Results|
www.americanbankingnews.com - March 14 at 9:42 AM
|InfuSystem (INFU) Board Initiates Share Buyback Program|
www.americanbankingnews.com - March 13 at 11:24 AM
|InfuSystem Holdings, Inc. Reports Fourth Quarter and Fiscal Year 2017 Results|
finance.yahoo.com - March 13 at 9:56 AM
|InfuSystem to Report Fourth Quarter 2017 Financial Results on Tuesday, March 13, 2018|
finance.yahoo.com - March 6 at 9:28 AM
|AWM Investment Company Inc. Has $3.48 Million Holdings in InfuSystem Holdings Inc (INFU)|
www.americanbankingnews.com - March 6 at 4:45 AM
|InfuSystem Holdings, Inc. Reports Interim Chief Financial Officer Will Leave Company at End of Current Quarter|
finance.yahoo.com - February 8 at 8:59 AM
|InfuSystem Holdings, Inc. Announces Dismissal of Class Action Shareholder Lawsuit|
finance.yahoo.com - January 31 at 4:34 PM
|ETFs with exposure to InfuSystem Holdings, Inc. : December 27, 2017|
finance.yahoo.com - December 27 at 3:03 PM
|InfuSystem Holdings, Inc. :INFU-US: Earnings Analysis: Q3, 2017 By the Numbers : December 26, 2017|
finance.yahoo.com - December 26 at 1:31 PM
|InfuSystem Holdings Inc (INFU) Director Meridian Ohc Partners, Lp Purchases 64,000 Shares|
www.americanbankingnews.com - December 14 at 9:20 PM
|ETFs with exposure to InfuSystem Holdings, Inc. : December 14, 2017|
finance.yahoo.com - December 14 at 3:17 PM
|InfuSystem Holdings Inc (INFU) Director Buys $16,790.00 in Stock|
www.americanbankingnews.com - December 8 at 6:46 PM
|Christopher R. Sansone Purchases 54,344 Shares of InfuSystem Holdings Inc (INFU) Stock|
www.americanbankingnews.com - November 22 at 2:02 PM
|BRIEF-Richard Diiorio appointed as president and CEO of Infusystem Holdings|
www.reuters.com - November 17 at 7:01 AM
|Richard DiIorio Appointed as President and Chief Executive Officer of InfuSystem Holdings, Inc.|
finance.yahoo.com - November 17 at 7:01 AM
InfuSystem (NYSEAMERICAN:INFU) SEC Filings
This page is loading this company's SEC Filings. Please wait...
InfuSystem (NYSEAMERICAN:INFU) Income Statement, Balance Sheet and Cash Flow Statement
InfuSystem (NYSEAMERICAN INFU) Stock Chart for Wednesday, March, 21, 2018